Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
SYNCYTIAL VIRUS STRAIN RB94, BOVINE RESPIRATORY
Pfizer Healthcare Ireland
QI02AD04
Powder for suspension for injection
Immunological - Live Vaccine
Bovine
2003-05-01
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10019/067/001 Case No: 7004155 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: PFIZER HEALTHCARE IRELAND TRADING AS PFIZER ANIMAL HEALTH, RINGASKIDDY, CO. CORK, IRELAND an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: RISPOVAL RS The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation, unless previously revoked, shall continue in force from 30/04/2008. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: From this date of effect, this authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 18/12/2008_ _CRN 7004155_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT RISPOVAL RS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of Rispoval RS contains the following : ACTIVE INGREDIENT(S) Live attenuated Bovine Respiratory Syncytial Virus, strain RB94 : minimum :10 CCID per dose. For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Powder for suspension for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and calves from 7 days of age. 4.2 INDICATIONS FOR USE, SPECI Прочитайте повний документ